Position in PGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,130,000
+$3,943,397 QoQ
Shares Held
900,000
+193.5% QoQ
Ownership
0.251%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#25
of 210 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Derivatives in PGEN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$9,690,000
PutShares
1,700,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. PGEN ranks #13 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
484,461 | $34,420,954 | |
| 2 | INSM |
INSMED Inc
|
236,000 | $25,162,320 | |
| 3 | ERAS |
Erasca, Inc.
|
1,041,225 | $19,075,242 | |
| 4 | CELC |
Celcuity Inc.
|
170,000 | $17,785,400 | |
| 5 | DSGN |
Design Therapeutics, Inc.
|
1,118,098 | $16,178,878 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
413,087 | $11,145,087 | |
| 7 | REPL |
Replimune Group, Inc.
|
783,873 | $8,677,474 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
120,700 | $7,596,858 |
All Filings in PGEN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,690,000 | 1,700,000 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $5,130,000 | 900,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,186,603 | 306,616 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $5,805,000 | 1,500,000 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $4,598,000 | 1,100,000 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $11,177,775 | 3,397,500 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $3,717,700 | 1,130,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $142,000 | 100,000 | Call | Sole | 2025-08-14 | |
| 2022-12-31 | $304,000 | 200,000 | Call | Sole | 2023-02-14 | |
| 2022-09-30 | $424,000 | 200,000 | Call | Sole | 2022-11-14 | |
| 2022-06-30 | $268,000 | 200,000 | Call | Sole | 2022-08-15 | |
| 2022-03-31 | $675,200 | 320,000 | Call | Sole | 2022-05-13 | |
| 2022-03-31 | $337,600 | 160,000 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $44,082 | 11,882 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $59,291 | 11,882 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $77,470 | 11,882 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $81,866 | 11,882 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $476,533 | 46,719 | Shares | Sole | 2021-02-16 | |
| 2020-12-31 | $1,108,740 | 108,700 | Put | Sole | 2021-02-16 | |
| 2020-09-30 | $22,750 | 6,500 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $32,435 | 6,500 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $22,100 | 6,500 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||